Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia — Stella

Home/Uterine Fibroids With Menorrhagia/Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia

View on ClinicalTrials.gov

Recruiting

Back to Uterine Fibroids With Menorrhagia trials

Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Peking University First Hospital, Beijing, Beijing Municipality

Key details

Phase

Safety & dosing

Sponsor

Shenzhen Kangzhe Biotechnology Co., Ltd.

Enrollment target

~120 participants

Started

February 2026

Primary completion

January 2027

Age range

18 Years – 50 Years

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.